TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro. - Wikidata - wikimedia - TriplyDB

TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro.

TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro.

http://www.wikidata.org/entity/Q39023976

about

Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins Expression and clinical significance of SATB1 and TLR4 in breast cancer.Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.

P2860

Q34501667-03D791C6-7057-4B4B-A465-91CBF9343F7F Q35796070-37DE5078-0DE7-4F3C-935C-FBE04C7400EA Q36297703-D7E3A923-9F9F-45C6-ABA2-7C6555028B42 Q36609391-D9FCE8B2-75CF-41D6-B627-1C9C62CF3764 Q37269094-E46B5A59-813E-4BE3-94C9-C236007283A2 Q37396607-DE0E5FC9-8698-4DF9-BD99-8196833EB7C5 Q41619770-61E9CF80-F100-4AE5-8CED-F7FAD71FD764 Q41702685-6C0F0615-CB08-40FF-B169-3D490C14099B Q41897007-37CDE2F6-FF7A-4068-9B9E-25DC858BAA5D Q52595047-C15A3D51-E733-40D0-9D67-B0E006D060A9 Q52730051-9794EDB8-559A-4D6A-A689-C82BC9481B35 Q53749471-A2358769-1502-4FE5-93B3-64E8BDF5EF42

P2860

TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro.

http://www.wikidata.org/entity/Q39023976

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@en

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@nl

type

label

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@en

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@nl

prefLabel

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@en

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@nl

P1433

Q39023976-1CE9AAF9-A187-43DE-8C42-303F728AE261

P1476

Q39023976-FDC90A0E-C4BF-40C8-A4A2-A7ADCE97D106

P2093

Q39023976-03538018-6BC4-41AC-A113-0AD57190CAE8

Q39023976-1A165267-FCA2-4EC5-912A-3E1A6C98ADA2

Q39023976-53A0373B-56B5-47F3-8B32-5F893FB6982A

Q39023976-96E83C4E-47AE-41D8-BBA8-DB893AED00D8

Q39023976-C85DA0A1-63A0-4771-929D-E1181DE96D0F

Q39023976-E94CC643-8F5C-4C15-B828-44809A95F199

Q39023976-F3B2A210-DA71-45FE-B9A0-2B19C948AB2A

Q39023976-FFA6158C-4EA9-473B-9D50-0718DB49C102

P2860

Q39023976-04D8D4D1-0B1E-4E70-88F2-767019925DFD

Q39023976-09A2FF4C-7545-4781-9EAF-AEC356753126

Q39023976-100669F0-A26B-44E7-83D3-969B6291BEF1

Q39023976-1C30E7EB-365D-41C8-9FA5-820214BC194F

Q39023976-1C5D88EE-5449-4934-9B8E-7AEDF65C8B2C

Q39023976-375D2EEC-56D1-420A-A66B-E85E3BF076E0

Q39023976-3F7980AB-F8EB-4AC5-83ED-18ED7F9B4F58

Q39023976-421A27F3-E281-431D-8537-B7CF83E432F2

Q39023976-4849C74D-734C-4007-8D9A-E853600DAD0F

Q39023976-54C310E1-D263-4C69-B3D7-017419483E94

P304

Q39023976-78BDD76E-B928-458A-A588-0CFE4696D7D2

P31

Q39023976-8B94FDF8-5C10-4B7B-B20C-54BD29ADE900

P356

Q39023976-29CEFEFB-A765-48A4-A8C5-5C74D7AEA661

P433

Q39023976-C56B0554-8800-4C9D-83FC-F6E54AA22B2C

P478

Q39023976-989F6434-8D58-494B-8F27-977FA52F3F07

P577

Q39023976-7862FB2E-6119-4476-8D39-166015944EE7

P5875

Q39023976-70DBEBF2-567C-4D99-BD14-DE26DD92355E

P698

Q39023976-C1A9B146-A3B8-4657-99CB-12A67CD41B2E

P921

Q39023976-37C41A25-5052-4B62-A4F4-FE245293F1FC

P932

Q39023976-B30B193B-83D8-4AC1-B6BA-5DFAB93F080F

P356

P1433

Oncology Letters

P1476

TLR4 induces tumor growth and ...... an ovarian carcinoma in vitro.

@en

P2093

An-Cong Wang

http://www.w3.org/2001/XMLSchema#string

Feng-Xia Wu

http://www.w3.org/2001/XMLSchema#string

Nai-Fu Liu

http://www.w3.org/2001/XMLSchema#string

Rong Gao

http://www.w3.org/2001/XMLSchema#string

Xiu-Gui Sheng

http://www.w3.org/2001/XMLSchema#string

Yong-Sheng Gao

http://www.w3.org/2001/XMLSchema#string

Yue-Bing Ma

http://www.w3.org/2001/XMLSchema#string

Zhi-Fang Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Toll-like receptors

Pathogen recognition and innate immunity

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages

Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6

Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Regulation of death receptor-mediated apoptosis pathways.

P304

871-877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1759

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260196892

http://www.w3.org/2001/XMLSchema#string

P698

24527095

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3919821

http://www.w3.org/2001/XMLSchema#string